dc.contributor.author | Aksu, Tolga | |
dc.contributor.author | SOYSAL, ALİ UĞUR | |
dc.contributor.author | Lyan, Evgeny | |
dc.contributor.author | Eitel, Charlotte | |
dc.contributor.author | Saygi, Serkan | |
dc.contributor.author | Turan, Oguzhan Ekrem | |
dc.contributor.author | Hegeer, Christian Hendrik | |
dc.contributor.author | Tilz, Roland Richard | |
dc.contributor.author | Ding, Wern Yew | |
dc.contributor.author | Gupta, Dhiraj | |
dc.contributor.author | YALIN, KIVANÇ | |
dc.contributor.author | İKİTİMUR, BARIŞ | |
dc.contributor.author | ÖZCAN, EMİN EVREN | |
dc.date.accessioned | 2022-07-04T14:09:02Z | |
dc.date.available | 2022-07-04T14:09:02Z | |
dc.identifier.citation | YALIN K., İKİTİMUR B., Aksu T., ÖZCAN E. E. , Ding W. Y. , SOYSAL A. U. , Lyan E., Eitel C., Saygi S., Turan O. E. , et al., "Catheter Ablation for Atrial Fibrillation in Patients <= 30 Years of Age", AMERICAN JOURNAL OF CARDIOLOGY, cilt.166, ss.53-57, 2022 | |
dc.identifier.issn | 0002-9149 | |
dc.identifier.other | av_6aa10bfb-9f94-40ac-a03a-8f1998bbe8a6 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/183160 | |
dc.identifier.uri | https://doi.org/10.1016/j.amjcard.2021.11.020 | |
dc.description.abstract | Pulmonary vein (PV) automaticity is an established trigger for paroxysmal atrial fibrillation (PAF), making PV isolation (PVI) the cornerstone of catheter ablation. However, data on triggers for atrial fibrillation (AF) and catheter ablation strategy in very young patients aged 30 seconds after a 3-month blanking period. A total of 2 patients with atrioventricular nodal reentrant tachycardia, 1 with left atrial appendage tachycardia, experienced AF recurrence within the first 3 months and received PVI. After the 3-month blanking period, during a median follow-up of 17.0 +/- 10.1 months, 44 of 51 patients (86.2%) were free of ATA recurrence. In the PVI group, 33 of 39 patients (84.6%) experienced no ATA recurrence. In conclusion, SVT substrate is identified in around a quarter of young adult patients with history of AF, and targeted ablation without PVI may be sufficient in the majority of these patients. PVI is needed in the majority and is safe and effective in this population. (C) 2021 Published by Elsevier Inc. | |
dc.language.iso | eng | |
dc.subject | Health Sciences | |
dc.subject | CARDIAC ve CARDIOVASCULAR SİSTEMLER | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Kardiyoloji | |
dc.subject | Cardiology and Cardiovascular Medicine | |
dc.title | Catheter Ablation for Atrial Fibrillation in Patients <= 30 Years of Age | |
dc.type | Makale | |
dc.relation.journal | AMERICAN JOURNAL OF CARDIOLOGY | |
dc.contributor.department | İstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü | |
dc.identifier.volume | 166 | |
dc.identifier.startpage | 53 | |
dc.identifier.endpage | 57 | |
dc.contributor.firstauthorID | 3403168 | |